Choose 96912 for psoralen plus UVA. Choose 96910 for the tar- or petrolatum-based UVB regimen.
On this page
CMS RVU26D · Effective 2026-10-01
96912 PUVA therapy Medicare reimbursement rates in Wyoming
Reports a PUVA treatment session pairing psoralen photosensitization with controlled UVA exposure for selected inflammatory or pigmentary skin disorders. Compare 96912 office and facility rates across CMS payment localities in Wyoming.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 96912 in Wyoming?
Wyoming has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$97.02
1 of 1 localities have a supported rate.
Payment area: Wyoming**
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Dermatology phototherapy
About 96912: Psoralen and UVA photochemotherapy
Reports a PUVA treatment session pairing psoralen photosensitization with controlled UVA exposure for selected inflammatory or pigmentary skin disorders.
PUVA combines a psoralen photosensitizer with ultraviolet A exposure to treat selected skin disorders. Dermatology practices use it for conditions such as psoriasis, vitiligo, and cutaneous T-cell lymphoma when a phototherapy course is prescribed. A trained staff member commonly administers or monitors the photosensitizer and delivers the measured UVA exposure in an outpatient phototherapy setting under physician supervision.
Report 96912 for the PUVA treatment session, rather than for UVB treatment or light exposure without psoralen. The record should identify the treated condition, the psoralen and UVA treatment provided, the exposure or dose information documented by the practice, and the supervising physician. CMS classifies this as an incident-to service: it may be billed only when performed under physician supervision.
CMS billing rules for 96912
- Professional and technical components
- Incident-to service: billed only when performed under physician supervision.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU2.89 · 99%
- Malpractice RVU0.02 · 1%
4.2K
Medicare services in 2024 · #1980 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
96912 compared with similar codes
Office rates for Wyoming, from the same CMS release.
96900 is ultraviolet actinotherapy; 96912 specifically requires a PUVA regimen combining psoralen and UVA.
96913 describes photochemotherapy for severe dermatoses requiring a more intensive service; 96912 identifies the PUVA treatment regimen.
Compare 96912 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Wyoming** →
Office / nonfacility
$97.02
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 96912 in Wyoming**.
PPRRVU2026_Oct_nonQPP.csv
12,828
- Code
- 96912
- Physician work
- 0.00
- Practice expense
- 2.89
- Malpractice
- 0.02
GPCI2026.csv
112
- Locality
- Wyoming**
- Physician work
- 1.000
- Practice expense
- 1.000
- Malpractice
- 0.740
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 2.89 | × 1.000 | 2.8900 |
| Malpractice | 0.02 | × 0.740 | 0.0148 |
| Total RVUs | 2.9048 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Wyoming**$97.02
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 2.89 | 1 |
| Malpractice | 0.02 | 0.74 |
(0 × 1 + 2.89 × 1 + 0.02 × 0.74) × $33.4009 = $97.02
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
96912 billing questions
How is 96912 different from 96910?
96912 is the psoralen-plus-UVA regimen. Code 96910 describes a different photochemotherapy approach using tar or petrolatum with UVB.
Can 96912 be reported for UV exposure without psoralen?
No. The treatment must include the psoralen component paired with UVA; UV treatment without psoralen is not PUVA.
What documentation supports 96912?
Document the condition treated, the psoralen and UVA session, the exposure or dose information maintained by the practice, and physician supervision.
May a staff member perform the session?
Yes, when the service is performed under physician supervision. CMS identifies 96912 as an incident-to service and permits billing only under that condition.
Is each treated body area a separate 96912 service?
The code represents the PUVA treatment session, not a separate service for each body area treated.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
